These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33551210)

  • 21. Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.
    Abbasi-Oshaghi E; Mirzaei F; Khodadadi I
    Prim Care Diabetes; 2021 Feb; 15(1):30. PubMed ID: 33162350
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes and COVID-19: What we learned from the two ongoing pandemics.
    Torquato MTDCG; Santis GC; Zanetti ML
    Rev Lat Am Enfermagem; 2021 Oct; 29():e3285. PubMed ID: 34730758
    [No Abstract]   [Full Text] [Related]  

  • 24. Increase in Diabetes Mortality Associated With COVID-19 Pandemic in the U.S.
    Ran J; Zhao S; Han L; Ge Y; Chong MKC; Cao W; Sun S
    Diabetes Care; 2021 Jul; 44(7):e146-e147. PubMed ID: 34135014
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 and diabetes in Africa: a lethal combination.
    Burki T
    Lancet Diabetes Endocrinol; 2022 Jan; 10(1):23. PubMed ID: 34856175
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
    Landstra CP; de Koning EJP
    Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?
    Tadic M; Cuspidi C
    J Clin Hypertens (Greenwich); 2021 Feb; 23(2):235-237. PubMed ID: 33369012
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 and diabetes: Covidiabetology.
    Kalra S; Mittal S
    J Pak Med Assoc; 2020 Jun; 70(6):954-955. PubMed ID: 32810084
    [No Abstract]   [Full Text] [Related]  

  • 29. What does SARS-CoV-2 tell us about the aetiology of environmental triggers for diabetes in children and young people?
    Ponmani C; Lyttle MD; Barrett M; Hulse T; Nijman RG; Roland D;
    Acta Paediatr; 2023 Dec; 112(12):2462-2464. PubMed ID: 37694855
    [No Abstract]   [Full Text] [Related]  

  • 30. Trends in Diabetes Care during the COVID-19 Outbreak in Japan: an Observational Study.
    Ikesu R; Miyawaki A; Sugiyama T; Nakamura M; Ninomiya H; Kobayashi Y
    J Gen Intern Med; 2021 May; 36(5):1460-1462. PubMed ID: 33469742
    [No Abstract]   [Full Text] [Related]  

  • 31. Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality?
    Salazar MR
    J Clin Hypertens (Greenwich); 2021 Feb; 23(2):232-234. PubMed ID: 33368990
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetic emergencies during the COVID-19 pandemic: A case-control study.
    Huda MSB; Shaho S; Trivedi B; Fraterrigo G; Chandrarajan L; Zolfaghari P; Dovey TM; Garrett CG; Chowdhury TA
    Diabet Med; 2021 Jan; 38(1):e14416. PubMed ID: 33025636
    [No Abstract]   [Full Text] [Related]  

  • 33. Prioritising action on diabetes during COVID-19.
    Erzse A; Fraser H; Levitt N; Hofman K
    S Afr Med J; 2020 Jun; 110(8):719-720. PubMed ID: 32880294
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes in the COVID-19 pandemic era.
    Bonansea TCP; Santos LPD; Zintl K; Souza ACDS
    Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region.
    Al Dawish MA; Robert AA
    Curr Diabetes Rev; 2021; 17(5):e211020187087. PubMed ID: 33087031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and COVID-19-the meeting of two pandemics: what are the concerns?
    Coppell KJ; Hall RM; Downie M; Fraser SK; Garrett M; Jefferies CA; Kenealy TW; Milne RE; Orr-Walker BJ; Paul RG; Smallman K; Snell HJ
    N Z Med J; 2020 May; 133(1514):85-87. PubMed ID: 32379745
    [No Abstract]   [Full Text] [Related]  

  • 37. Service restriction during the COVID-19 pandemic and its impact on HbA
    Batten L; Chandrajay D; Burkinshaw C; Gill J; Jayagopal V
    Diabet Med; 2021 Jan; 38(1):e14414. PubMed ID: 33030220
    [No Abstract]   [Full Text] [Related]  

  • 38. Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19.
    Beran D; Aebischer Perone S; Castellsague Perolini M; Chappuis F; Chopard P; Haller DM; Jacquerioz Bausch F; Maisonneuve H; Perone N; Gastaldi G
    Prim Care Diabetes; 2021 Feb; 15(1):16-17. PubMed ID: 32535088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people.
    Bonora E; Fedeli U; Schievano E; Trombetta M; Saia M; Scroccaro G; Tacconelli E; Zoppini G
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2612-2618. PubMed ID: 34348880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New-onset diabetes in "long COVID".
    Sathish T; Anton MC; Sivakumar T
    J Diabetes; 2021 Aug; 13(8):693-694. PubMed ID: 33893710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.